IBD Evidence

Comharthaí

Ag maireachtáil le IBD: tuirse, pian agus na codanna nach gcuirtear tomhas orthu

Tá difríocht idir conradh ar pháipéar agus conradh mar a mhothaítear, agus is ann a mhaireann an chuid is mó den ualach.

Nuashonraithe 3 min léamh 22 tagairtí Láidir an fhianaise 3/5

Tuirse

Is é tuirse ceann de na comharthaí a thuairiscítear go minic i IBD agus tá sé ar na comharthaí is lú a chóireáiltear. Maireann sé i gcodanna móra de dhaoine a bhfuil a n-athlasadh faoi smacht, rud a chiallaíonn nach marc é de ghníomhaíocht ghalair amháin.

Cuireann anaemia (tá easpa iarainn an-choitianta agus inchoigeartaithe), cur isteach ar chodladh, éifeachtaí drugaí, athlasadh crónach, agus an ualach síceolaíoch de ghalar neamhthuigthe le chéile. Tá na cinn inchoigeartaithe fiúntach a chur i gcuimhne go sonrach, mar ní ardóidh aon duine iad duit i gcruinniú cúig nóiméad atá dírithe ar calprotectin.

Ualach tuirse i IBD

Sláinte mheabhrach

Tá rátaí imní agus dúlagar i IBD ag dul thar na rátaí cúlra go suntasach. Is é an míniú soiléir — tá maireachtáil le galar neamhthuigthe, stigmatized, a d'fhéadfadh incontinence a chur faoi deara, ag cur isteach — fíor agus is dócha nach é an scéal iomlán é, ag breathnú ar na cosáin athlastacha agus gut-brain atá clúdaithe ar ár suíomh fianaise gut-brain.

Is é an rud atá tábhachtach go praiticiúil ná go bhfuil sé inchoigeartaithe agus go gcuirtear in iúl go rialta. Tá tacaíocht síceolaíoch mar chuid de chúram IBD i dtreoirlínte na hEorpa agus tá sé á sholáthar go neamhrialta.

An ualach praiticiúil

  • Imní maidir le rochtain ar leithligh, a chuireann cosc ar thaisteal, obair agus saol sóisialta níos mó ná mar a thuigeann cliniceoirí go ginearálta.
  • Neamhthuigtheacht. Tá pleanáil deacair nuair a d'fhéadfadh flare teacht gan rabhadh.
  • Bainistíocht aiste bia. Tosaíochtaí aonair, níl liosta bailí ann, agus go leor comhairle contrártha — féach aiste bia.
  • Fostaíocht. Déanann tuirse agus éigeandáil comhoibriú go dona le patrúin oibre docht.
  • Taisteal. Stóráil drugaí, sábháilteacht bia agus rochtain — clúdaithe ar ár suíomh sláinte taistil.

Eipidéimeolaíocht

Tá an t-ionsaí IBD ard agus cobhsaí san Eoraip agus i dTuaisceart na hAmerice agus ag ardú go géar i dtíortha nua-thionscanta. Is é an patrún geografach sin ceann de na hargóintí is láidre maidir le comhpháirt chomhshaoil — tá aiste bia, sláinte, antaibheathaigh agus an microbiome go léir ina n-iarrthóirí, agus níl aon cheann bunaithe.

Ceisteanna coitianta

Cén fáth a bhfuil mé tuirseach más atá mé i gconradh?
Maireann tuirse go minic tar éis smacht athlastach. Seiceáil ferritin agus B12 ar dtús; tá siad coitianta, inchoigeartaithe agus go minic caillte.
An bhfuil strus ag cúiseanna mo flares?
Is féidir le strus tionchar a imirt ar chomharthaí agus tá an fianaise a léiríonn go gcuireann sé athlasadh faoi deara níos laige ná an samhail phobail. Ní do locht é.
An mbeidh gá dom le máinliacht?
Déantar cuid shubstaintiúil de, agus tá an cóimheas laghdaithe de réir mar a tháinig cóireáil éifeachtach níos luaithe — féach cóireáil.
An féidir liom taisteal?
Sea, le pleanáil maidir le drugaí, árachas agus sábháilteacht bia.

Tagairtí

Gach tagairt thíos a nascann leis an taifead peer-reviewed bunaidh ar PubMed nó trí DOI. Ní rud ar bith anseo a chuireann comhairle leighis in ionad.

  1. Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization Assa A, Aloi M, Van Biervliet S, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40528309
  2. Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation Wine E, Aloi M, Van Biervliet S, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40677018Full text
  3. Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns Steinmann M, Lampe D, Grosser J, et al. · Infection · 2024 · Meta-analysis DOIPubMed 38236326Full text
  4. Acute severe ulcerative colitis trials: the past, the present and the future Honap S, Jairath V, Sands BE, et al. · Gut · 2024 · Systematic review DOIPubMed 38834296Full text
  5. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses Buie MJ, Quan J, Windsor JW, et al. · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023 · Meta-analysis DOIPubMed 35863682
  6. Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease Valvano M, Capannolo A, Cesaro N, et al. · Nutrients · 2023 · Systematic review DOIPubMed 37686856Full text
  7. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review Kuenzig ME, Fung SG, Marderfeld L, et al. · Gastroenterology · 2022 · Systematic review DOIPubMed 34995526
  8. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis Barberio B, Zamani M, Black CJ, et al. · The lancet. Gastroenterology & hepatology · 2021 · Meta-analysis DOIPubMed 33721557
  9. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD Turner D, Ricciuto A, Lewis A, et al. · Gastroenterology · 2021 · Systematic review DOIPubMed 33359090
  10. ACG Clinical Guideline: Management of Irritable Bowel Syndrome Lacy BE, Pimentel M, Brenner DM, et al. · The American journal of gastroenterology · 2021 · Clinical guideline DOIPubMed 33315591
  11. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies Ng SC, Shi HY, Hamidi N, et al. · Lancet (London, England) · 2017 · Systematic review DOIPubMed 29050646
  12. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target Peyrin-Biroulet L, Sandborn W, Sands BE, et al. · The American journal of gastroenterology · 2015 · Systematic review DOIPubMed 26303131
  13. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study Ferrante M, D'Haens G, Jairath V, et al. · Lancet (London, England) · 2024 · Randomised controlled trial DOIPubMed 39581202
  14. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial Cox SR, Lindsay JO, Fromentin S, et al. · Gastroenterology · 2020 · Randomised controlled trial DOIPubMed 31586453
  15. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis Sands BE, Peyrin-Biroulet L, Loftus EV Jr, et al. · The New England journal of medicine · 2019 · Randomised controlled trial DOIPubMed 31553834
  16. Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies Caron B, Honap S, Peyrin-Biroulet L · Journal of Crohn's & colitis · 2024 · Review DOIPubMed 39475082Full text
  17. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life Nguyen TV, Damiani G, Orenstein LAV, et al. · Journal of the European Academy of Dermatology and Venereology : JEADV · 2021 · Review DOIPubMed 32460374
  18. Iron Deficiency Anemia in Inflammatory Bowel Diseases-A Narrative Review Mahadea D, Adamczewska E, Ratajczak AE, et al. · Nutrients · 2021 · Review DOIPubMed 34836263Full text
  19. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities Elmets CA, Leonardi CL, Davis DMR, et al. · Journal of the American Academy of Dermatology · 2019 · Review DOIPubMed 30772097
  20. Fatigue in inflammatory bowel disease Grimstad T, Norheim KB · Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke · 2016 · Review DOIPubMed 27830906
  21. Global evolution of inflammatory bowel disease across epidemiologic stages Hracs L, Windsor JW, Gorospe J, et al. · Nature · 2025 · Journal article DOIPubMed 40307548Full text
  22. Psychological symptoms and quality of life in patients with inflammatory bowel disease in China: A multicenter study Zhang J, Liu C, An P, et al. · United European gastroenterology journal · 2024 · Journal article DOIPubMed 38315582Full text

Taispeánadh an leathanach seo go huathoibríoch ó Bhéarla. Ní athraítear na tagairtí agus na huimhreacha. Léigh an t-údarás Béarla má léitear rud ar bith go neamhréireach. Léigh an t-údarás Béarla